Resumo

RODRIGUEZ-ALMENDROS, Nielzer et al. Portopulmonary hypertension: Updated review. Arch. Cardiol. Méx. [online]. 2018, vol.88, n.1, pp.25-38. ISSN 1665-1731.  https://doi.org/10.1016/j.acmx.2016.11.002.

Portopulmonary hypertension (PPH) is a rare condition worldwide, although epidemiological data are unknown in Mexico. However, chronic liver diseases are very prevalent in Mexico. PPH is the 4th subtype in frequency in the group of pulmonary arterial hypertension. Its diagnosis is made within 2 scenarios: patients with suspected pulmonary hypertension and candidates for orthotopic liver transplantation (OLT). Both echocardiogram and a right cardiac catheterisation are crucial for diagnosis in both cases. PPH is a challenge for OLT, since it can significantly increase perioperative mortality. The use of specific therapy is the cornerstone of this disease, as a measure to improve the outcome of those who become candidates for OLT with moderate to severe PPH. It is important to recognise that PPH can be a contraindication to OLT. The role of lung-liver transplantation or heart-lung-liver transplantation as a measure to heal pulmonary vascular disease in patients with PPH is still uncertain.© 2016 Instituto Nacional de Cardiolog´ıa Ignacio Cha´vez. Published by Masson Doyma Me´xico S.A. This is an open access article under the CC BY-NC-ND license (http://creativecommons. org/licenses/by-nc-nd/4.0/).

Palavras-chave : Pulmonary arterial hypertension; Liver cirrhosis; Liver transplantation; Mexico.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )